Tracking political contributions from insulin manufacturers can expose politicians' potential bias towards the pharmaceutical industry. Public scrutiny can deter politicians from supporting biased policies that favor the industry at the expense of people with diabetes.

Is your representative taking money from insulin makers? Ask them about their stance on affordable insulin.